Global Patient-derived Xenograft Models Market
Global Patient-derived Xenograft Models Market
Report Includes
- An overview of the global PDX models market, with revenue in $billions for 2025, estimates for 2026 and forecasts through 2031
- Analysis of mice and rat models, including subcutaneous, orthotopic and other implantation methods
- Coverage of gastrointestinal, gynecological, respiratory, urological, hematological and other tumor models
- A review of end users, including pharmaceutical and biotechnology companies, CROs and CDMOs, and academic research institutes
- Discussion of market drivers, growth opportunities and challenges, including development costs, maintenance needs and lengthy study periods
- Analysis of macroeconomic factors and market competition through PESTEL and Porter’s Five Forces analysis
- Insights into emerging technologies and developments in PDX models
- Regional coverage of North America, Europe, Asia-Pacific and the rest of the world
- Profiles of key companies, including their strategies, financial information, product portfolios and recent developments